CHASE DONALD R 4

What Happened Donald R. Chase, a director of Bluejay Diagnostics (BJDX), purchased 12,500 shares of the company's common stock in a private placement on March 14, 2026. The shares were acquired at $2.00 per share for a total cash outlay of $25,000. This was a purchase (insider acquisition), which investors often view as a more informative signal than routine sales.

Key Details

• Transaction date and terms: March 14, 2026 — private purchase (Code P), 12,500 shares at $2.00 per share; total $25,000.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnote: The filing notes the shares were purchased from the issuer in a private placement.
• Filing timeliness: The Form 4 was filed on May 18, 2026 for a March 14 transaction — this is a late filing relative to the usual two-business-day reporting requirement.

Context This was a direct purchase from the company (private placement) rather than an open-market trade; such purchases can be part of company financings or negotiated arrangements and may carry different implications than market purchases. The filing provides transaction details but does not disclose post-transaction holdings or the rationale for the purchase; absence of those details means investors should treat this as a factual disclosure without inferring motive.